Anti-PD-1 Therapy Achieved Disease Control After Multiline Chemotherapy in Unresectable KRAS-Positive Hepatoid Lung Adenocarcinoma: A Case Report and Literature Review

Hepatoid adenocarcinoma of the lung (HAL) is extremely rare and standardized treatment strategy for HAL has not been established. Patients with unresectable HAL have a shorter survival time ranges from 1 to 36 months. Here, we reported a 65-year-old female patient with unresectable alpha-fetoprotein...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lulu, Han, Xue, Gao, Yujuan, Zhao, Qi, Wang, Yongsheng, Jiang, Ya, Liu, Sisi, Wu, Xue, Miao, Liyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245476/
https://www.ncbi.nlm.nih.gov/pubmed/32547068
http://dx.doi.org/10.2147/OTT.S248226

Ejemplares similares

Ejemplares similares